Kai Hu: Clinical Trials

1 trial sponsored by Kai Hu, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Not yet recruiting 1

Follow Kai Hu: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Becotatug Vedotin as Adjuvant Therapy For High-risk Nasopharyngeal Carcinoma
Becotatug Vedotin - Nasopharyngeal Carcinoma (NPC), Locoregionally Advanced Nasopharyngeal Carcinoma
Phase 2Not yet recruitingKai Hu1402026-09-012026-06-09

Conditions studied

Nasopharyngeal Carcinoma (1)

Countries

China (1)